Orion Pharma AG - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

orion temozolomide

orion laboratories (nz) ltd - temozolomide 250mg - capsule - 250 mg - active: temozolomide 250mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

New Zealand - English - Medsafe (Medicines Safety Authority)

orion temozolomide

orion laboratories (nz) ltd - temozolomide 5mg - capsule - 5 mg - active: temozolomide 5mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint green sb-4020 titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacy care nicotine chewing gum 4mg mint flavour blister pack

orion laboratories pty ltd t/a perrigo australia - nicotine, quantity: 4 mg - gum, chewing - excipient ingredients: sorbitol; acesulfame potassium; mannitol; titanium dioxide; sodium carbonate; peppermint oil; gelatin; glycerol; saccharin; calcium carbonate; sodium bicarbonate; polacrilin; purified water; mint oil dementholised; eucalyptus oil; menthol; xylitol; carnauba wax; saccharin sodium; synthetic terpene resin; polyvinyl acetate; mono- and di- glycerides - an aid in the cessation of smoking in smokers with nicotine dependence. pharmacy care nicotine coated chewing gums may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping completely.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacy care nicotine chewing gum 2mg mint flavour blister pack

orion laboratories pty ltd t/a perrigo australia - nicotine, quantity: 2 mg - gum, chewing - excipient ingredients: mint oil dementholised; acesulfame potassium; sodium bicarbonate; sodium carbonate; eucalyptus oil; saccharin; carnauba wax; gelatin; polacrilin; saccharin sodium; purified water; glycerol; mannitol; xylitol; peppermint oil; titanium dioxide; sorbitol; calcium carbonate; menthol; synthetic terpene resin; polyvinyl acetate; mono- and di- glycerides - an aid in the cessation of smoking in smokers with nicotine dependence. pharmacy care nicotine coated chewing gums may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping completely.